Lipes M A, Rosenzweig A, Tan K N, Tanigawa G, Ladd D, Seidman J G, Eisenbarth G S
Joslin Diabetes Center, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115.
Science. 1993 Feb 19;259(5098):1165-9. doi: 10.1126/science.8267690.
The T cell receptor (TCR) requirements in the pathogenesis of insulin-dependent diabetes were examined with transgenic NOD mice bearing nondisease-related TCR alpha and beta chains. In both TCR beta and TCR alpha beta transgenic NOD mice the beta chain transgene was expressed by > 98% of peripheral T cells. The alpha chain transgene was also highly expressed. Insulitis developed in both sets of transgenic animals with most of the lymphocytes in the lesion expressing the transgenic beta chain and with depletion of the endogenous TCR V beta genes. Nonetheless, NOD animals transgenic for TCR beta and TCR alpha beta developed diabetes similar to controls. Thus, skewing the TCR repertoire did not diminish autoimmune susceptibility in NOD mice.
利用携带与疾病无关的T细胞受体α和β链的转基因非肥胖型糖尿病(NOD)小鼠,研究了胰岛素依赖型糖尿病发病机制中的T细胞受体(TCR)需求。在TCRβ和TCRαβ转基因NOD小鼠中,β链转基因在外周T细胞中的表达率均>98%。α链转基因也高度表达。两组转基因动物均发生胰岛炎,病变中的大多数淋巴细胞表达转基因β链,内源性TCR Vβ基因耗竭。尽管如此,TCRβ和TCRαβ转基因的NOD动物发生的糖尿病与对照组相似。因此,改变TCR库并不会降低NOD小鼠的自身免疫易感性。